Kazia Therapeutics (KZIA) Other Non Operating Income (2009 - 2013)

Kazia Therapeutics' (KZIA) quarterly Other Non Operating Income came in at $452626.6 in Q2 2010, up 225.03% on a QoQ basis from -$362000.0 in Q4 2009.

Kazia Therapeutics (KZIA) Other Non Operating Income (2009 - 2013) Analysis & Trends

Kazia Therapeutics (KZIA) has 2 years of Other Non Operating Income data on file, last reported at $452626.6 in Q2 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Kazia Therapeutics 4.22 Bn 4.22 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2013 -399,363.01
Dec 31, 2012 -514,998.65
Dec 31, 2011 -492,381.47
Jun 30, 2010 452,626.58
Dec 31, 2009 -362,000.00